Biotech for less than cash value Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech for less than cash value

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: rkrw	5/9/2022 9:08:02 PM
	1 Recommendation Recommended By ghmm Read Replies (1) of 684

Some not so fun stats on this bear mauling My database has 640+ names Median 2022 YTD -49.1% (on top of -42.2% last year) For 2022: 41 names are up any amount 602 down 3 have 2x (nvct, trvi, nwbo) 11 are up 30% or more 317 down 50% or more 185 down 60% or more 87 down 70% or more 27 down 80% or more 255 names sub cash (39.6%)-- ***most not updated for Q1 cash mind you ~100 at half cash ~40 at 1/3rd cash 14 at 1/4th of cash 41 of the 42 lowest market cap names are sub cash, tells you the market isn't expecting any of them to stick around long. Cumulatively down $224b which understates it by some billions as new names have been added for IPO's etc.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next